• Surgical Management of Obesity in Brazil: Proposal for a Value-Based Healthcare Model and Preliminary Results

    Dec 1, 2021, 00:00

  • Cost-Effectiveness of the Dabrafenib Schedule in Combination With Trametinib Compared With Other Targeted Therapies, Immunotherapy, and Dacarbazine for the Treatment of Unresectable or Metastatic Melanoma With BRAFV600 Mutation in Colombia

    Dec 1, 2021, 00:00

  • Cost-Effectiveness Analysis of Prostate Cancer Screening in Brazil [Editor's Choice]

    Dec 1, 2021, 00:00

  • Different Alternatives to Assess the Burden of Disease Using Attributable Fraction on a Disability Variable: The Case of Pain and Chronic Musculoskeletal Disorders in Chile [Editor's Choice]

    Dec 1, 2021, 00:00

  • Estimation of Health-Related Quality of Life Losses Owing to a Technological Disaster in Brazil Using EQ-5D-3L: A Cross-Sectional Study

    Dec 1, 2021, 00:00

  • Table of Contents

    Dec 1, 2021, 00:00

  • Anti-Interleukin-5 in the Management of Eosinophilic Asthma: A Review of Effectiveness, Safety, and Budgetary Impact From the Perspective of the Brazilian Health System

    Dec 1, 2021, 00:00

  • Optimal Allocation of Chemotherapy Schemes for Metastatic Colon Cancer in Colombia

    Dec 1, 2021, 00:00

  • Pharmacoeconomic Analysis of Sitagliptin/Metformin for the Treatment of Type 2 Diabetes Mellitus: A Cost-Effectiveness Study

    Dec 1, 2021, 00:00

  • Editorial Board

    Dec 1, 2021, 00:00

  • Health-Related Quality of Life in Psoriatic Arthritis: Findings and Implications

    Dec 1, 2021, 00:00

  • EQ-5D-5L Population Norms and Health Inequality in Colombia

    Dec 1, 2021, 00:00

  • Cost-Utility Analysis of Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria From the Perspective of the Brazilian Public Health System

    Dec 1, 2021, 00:00

  • Estimation of Prevalence and Incremental Costs of Systemic Lupus Erythematosus in a Middle-Income Country Using Machine Learning on Administrative Health Data

    Dec 1, 2021, 00:00

  • Surrogate Endpoints in Oncology: Overview of Systematic Reviews and Their Use for Health Decision Making in Mexico

    Dec 1, 2021, 00:00

  • Copyright/Subscription

    Nov 29, 2021, 08:28

  • Copyright/Subscription

    Sep 7, 2021, 09:10

  • Can We Incorporate Societal Values in Resource Allocation Decisions Among Disease Categories? An Empirical Approach

    Sep 1, 2021, 00:00

  • Assessment of Health-Related Quality of Life Among Patients Infected With HIV Receiving Care in a Nigerian Tertiary Hospital

    Sep 1, 2021, 00:00

  • Value in Health Regional Issues: Reflections and Challenges After a Decade

    Sep 1, 2021, 00:00

  • Editorial Board

    Sep 1, 2021, 00:00

  • Evidence-Based Care Reduces Unnecessary Medical Procedures and Healthcare Costs in the Outpatient Setting

    Sep 1, 2021, 00:00

  • Assessment of Utility in Migraine: Mapping the Migraine-Specific Questionnaire to the EQ-5D-5L

    Sep 1, 2021, 00:00

  • Table of Contents

    Sep 1, 2021, 00:00

  • Patient Perspectives and Willingness to Accept Incentives for Tuberculosis Diagnostic Evaluation in Uganda

    Sep 1, 2021, 00:00

  • The Cost-Effectiveness of Adjuvant Tamoxifen Treatment of Hormone Receptor–Positive Early Breast Cancer Among Premenopausal and Perimenopausal Ghanaian Women

    Sep 1, 2021, 00:00

  • A Systematic Review of Potentially Inappropriate Medications Use and Related Costs Among the Elderly

    Sep 1, 2021, 00:00

  • Pharmacoeconomics Education in the Middle East and North Africa Region: A Web-Based Research Project

    Sep 1, 2021, 00:00

  • Persistent Socioeconomic Inequalities in Measles Vaccine Uptake in Ethiopia in the Period 2005 to 2016

    Sep 1, 2021, 00:00

  • Reporting Quality of Cost-Effectiveness Analyses Conducted in Saudi Arabia: A Systematic Review

    Sep 1, 2021, 00:00

  • Cost-Effectiveness Analysis of Community Case Management of Childhood Diarrhea in Burundi [Editor's Choice]

    Sep 1, 2021, 00:00

  • Modeling and Forecasting Foreign Trade Values in Medical Devices

    Sep 1, 2021, 00:00

  • A Systematic Literature Review of Preference-Based Health-Related Quality-of-Life Measures Applied and Validated for Use in Childhood and Adolescent Populations in Sub-Saharan Africa

    Sep 1, 2021, 00:00

  • Economic Evaluation of Cladribine Tablets in Patients With High Disease Activity–Relapsing-Remitting Multiple Sclerosis in the Kingdom of Saudi Arabia [Editor's Choice]

    Sep 1, 2021, 00:00

  • The Association Between Physical Performance and Health-Related Quality of Life Based on the EQ-5D-3L Questionnaire in Patients With Chagas Disease

    Sep 1, 2021, 00:00

  • Impact of Immunoablation and Autologous Hematopoietic Stem Cell Transplantation on Treatment Cost of Multiple Sclerosis: Real-World Nationwide Study

    Sep 1, 2021, 00:00

  • Evaluation of the Availability of Hospital-Based Health Technology Assessment in Public and Private Hospitals in Turkey: Ankara Province Sample

    Sep 1, 2021, 00:00

  • A Protocol for Developing a Discrete Choice Experiment to Elicit Preferences of General Practitioners for the Choice of Specialty

    Sep 1, 2021, 00:00

  • Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey

    Sep 1, 2021, 00:00

  • Annual Costs Incurred in Managing Adverse Drug Reactions Attributable to Fixed-Dose Combination Highly Active Antiretroviral Therapy in an Outpatient Antiretroviral Clinic in Gauteng: A Budget Impact Analysis

    Sep 1, 2021, 00:00

  • Development and Validation of the New Asthma Numeracy Test

    Sep 1, 2021, 00:00

  • Implementation Road Map of Health Technology Assessment in Middle-Income Countries: The Case of Jordan [Editor's Choice]

    Sep 1, 2021, 00:00

  • Cost-Effectiveness of a Culturally Adapted Manual-Assisted Brief Psychological Intervention for Self-Harm in Pakistan: A Secondary Analysis of the Culturally Adapted Manual-Assisted Problem-Solving Training Randomized Controlled Trial

    Sep 1, 2021, 00:00

  • Economic Burden of Urinary Tract Infections From Antibiotic-Resistant Escherichia coli Among Hospitalized Adult Patients in Lebanon: A Prospective Cohort Study

    Sep 1, 2021, 00:00

  • Price, Availability, and Affordability of Antineoplastic Medicines in Harare’s Public and Private Institutions: Implication for Access

    Sep 1, 2021, 00:00

  • Preferences of Patients With HR+ and HER2− Breast Cancer Regarding Hormonal and Targeted Therapies in the First Line of Their Metastatic Stage: A Discrete Choice Experiment

    Sep 1, 2021, 00:00

  • May the Cleaning of Prescriptive Documents Using Best Evidence Reduce the Cost of Prescribed Healthcare?

    Sep 1, 2021, 00:00

  • Copyright/Subscription

    Jun 1, 2021, 08:40

  • Table of Contents

    May 1, 2021, 00:00

  • Out-of-Pocket Costs and Importance of Nonmedical and Indirect Costs of Inpatients

    May 1, 2021, 00:00

  • Contingent Valuation: A Pilot Study for Eliciting Willingness to Pay for a Reduction in Mortality From Vaccine-Preventable Illnesses for Children and Adults in Bangladesh

    May 1, 2021, 00:00

  • Health Technology Assessment in Australia: The Pharmaceutical Benefits Advisory Committee and Medical Services Advisory Committee

    May 1, 2021, 00:00

  • Importance of Evidence-Based Health Insurance Reimbursement and Health Technology Assessment for Achieving Universal Health Coverage and Improved Access to Health in India

    May 1, 2021, 00:00

  • Facing the Threat of COVID-19 in Pakistan: A Nation’s Dilemma

    May 1, 2021, 00:00

  • Using Contingent Valuation Method to Estimate Adults’ Willingness to Pay for a Future Coronavirus 2019 Vaccination

    May 1, 2021, 00:00

  • Cost-Effectiveness of Mirogabalin for the Treatment of Diabetic Peripheral Neuropathic Pain in Taiwan

    May 1, 2021, 00:00

  • Is It Worth Delaying Total Knee Replacement as Late as Possible? A Cost-Effectiveness Analysis Using a Markov Model in the Indian Setting

    May 1, 2021, 00:00

  • Current Status of Research on the Mapping Function of Health Utility Values in the Asia Pacific Region: A Systematic Review [Editor's Choice]

    May 1, 2021, 00:00

  • Enhancing Health Technology Assessment Establishment in Asia: Practical Issues From the Pharmaceutical and Medical Device Industry Perspectives

    May 1, 2021, 00:00

  • Cost-Effectiveness of Juluca for Human Immunodeficiency Virus Infection Treatment in Virologically Suppressed Adults in Taiwan [Editor's Choice]

    May 1, 2021, 00:00

  • Editorial Board

    May 1, 2021, 00:00

  • Economic Viability and Efficacy of Day Case Versus Inpatient Tonsillectomy in Southern Iran

    May 1, 2021, 00:00

  • Health-Related Quality of Life Among Children With Pneumonia in Indonesia Using the EuroQoL Descriptive System Value Set for Indonesia

    May 1, 2021, 00:00

  • Development and Validation of a Chronic Kidney Disease Prediction Model for Type 2 Diabetes Mellitus in Thailand

    May 1, 2021, 00:00

  • Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country

    May 1, 2021, 00:00

  • Suggestions to Make Health Technology Assessment in India an Efficient Process

    May 1, 2021, 00:00

  • Cost-Effective Analysis of the Congenital Hypothyroidism Screening Program in Sri Lanka

    May 1, 2021, 00:00

  • Predictors of Health-Related Quality-of-Life Status Among Elderly Patients With Cardiovascular Diseases

    May 1, 2021, 00:00

  • Coronavirus Disease 2019 in 5 Neighboring Limited-Resource Countries: A Financial and Health Threat

    May 1, 2021, 00:00

  • Current Development and Practice of Pharmacoeconomic Evaluation Guidelines for Universal Health Coverage in China

    May 1, 2021, 00:00

  • Patient Journey and Disease-Related Burden in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension: A Mixed Methods Study [Editor's Choice]

    May 1, 2021, 00:00

  • Economic Burden of Stroke in Iran: A Population-Based Study

    May 1, 2021, 00:00

  • Addressing Challenges in Health Technology Assessment Institutionalization for Furtherance of Universal Health Coverage Through South-South Knowledge Exchange: Lessons From Bhutan, Kenya, Thailand, and Zambia [Editor's Choice]

    May 1, 2021, 00:00

  • Mapping Utility Scores From the HeartQoL Questionnaire Into the EQ-5D for Ischemic Heart Disease

    May 1, 2021, 00:00

  • A Study Comparing Cost-Effectiveness of Combination Therapy for Preventing Opportunistic Infections Among Human Immunodeficiency Virus–Infected Adults on Antiretroviral Therapy

    May 1, 2021, 00:00

  • Consumer Preferences and Willingness to Pay for Nutraceuticals: A Discrete Choice Experiment [Editor's Choice]

    May 1, 2021, 00:00

  • Similarities and Differences in Health-Related Quality-of-Life Concepts Between the East and the West: A Qualitative Analysis of the Content of Health-Related Quality-of-Life Measures

    May 1, 2021, 00:00

  • Socioeconomic Impact of Hospitalization Expenditure for Treatment of Noncommunicable Diseases in India: A Repeated Cross-Sectional Analysis of National Sample Survey Data, 2004 to 2018

    May 1, 2021, 00:00

  • A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infections in an Adult-Outpatient Setting in Japan

    May 1, 2021, 00:00

  • Cost-Effectiveness of Lenvatinib in the Treatment of Patients With Unresectable Hepatocellular Carcinomas in Japan: An Analysis Using Data From Japanese Patients in the REFLECT Trial

    May 1, 2021, 00:00

  • Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome

    May 1, 2021, 00:00

  • Validity of the Malay EQ-5D-3L in the Malaysian Transfusion-Dependent Thalassemia Population

    May 1, 2021, 00:00

  • Reviewer Acknowledgment

    Dec 16, 2020, 17:31

  • Copyright/Subscription

    Dec 9, 2020, 11:53

  • Omitted Conflict of Interest Disclosures in Previously Published Articles

    Dec 1, 2020, 00:00

  • 24/7 Physical Therapy Intervention With Adult Patients in a Chilean Intensive Care Unit: A Cost-Benefit Analysis in a Developing Country

    Dec 1, 2020, 00:00

  • Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia

    Dec 1, 2020, 00:00

  • What Do Doctors Think About Value-Based Healthcare? A Survey of Practicing Physicians in a Private Healthcare Provider in Brazil (Editor's Choice)

    Dec 1, 2020, 00:00

  • Willingness of Infertile Couples to Pay for In Vitro Fertilization Treatment in the Integrated Human Reproduction Section of the Escola Paulista de Medicina, São Paulo Federal University

    Dec 1, 2020, 00:00

  • Satisfaction With Healthcare Services Among Patients With Diabetes, Hypertension, and/or Dyslipidemia in Mexico: A Cross-Sectional Study

    Dec 1, 2020, 00:00

  • Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making?

    Dec 1, 2020, 00:00

  • Editorial Board

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis and Budget Impact: Antimuscarinics and Mirabegron for the Treatment of Patients With Urge Urinary Incontinence: The Brazilian Public Health System Perspective

    Dec 1, 2020, 00:00

  • Cost-Effectiveness of the Addition of Bevacizumab to First-Line Chemotherapy With Carboplatin and Paclitaxel in Patients With Non–Small Cell Lung Cancer

    Dec 1, 2020, 00:00

  • International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the Literature

    Dec 1, 2020, 00:00

  • Cost Analysis of Cancer in Brazil: A Population-Based Study of Patients Treated by Public Health System From 2001-2015 (Editor's Choice)

    Dec 1, 2020, 00:00

  • How Educational Inequalities in Cardiovascular Mortality Evolve While Healthcare Insurance Coverage Grows: Colombia, 1998 to 2015

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Point-of-Care Rapid Testing Versus Laboratory-Based Testing for Antenatal Screening of Syphilis in Brazil

    Dec 1, 2020, 00:00

  • Treatment Satisfaction Questionnaire for Medication (TSQM version 1.4): Ceiling and Floor Effects, Reliability, and Known-Group Validity in Brazilian Outpatients With Hypertension

    Dec 1, 2020, 00:00

  • Costs Associated With Early Vascular and Biliary Complications in Liver-Transplanted Patients in a Hospital in Antioquia, Colombia 2019: A Case Series

    Dec 1, 2020, 00:00

  • Adaptation and Validation of the Health Belief Model Scale for Breast Self-Examination in Mexican Women

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Rehabilitation Interventions for Teeth With Extensive Coronary Destruction

    Dec 1, 2020, 00:00

  • Limitations and Challenges of Conducting Budget Impact Analyses in Rare Diseases: A Case Study of Alpha-1 Antitrypsin Deficiency (Editor's Choice)

    Dec 1, 2020, 00:00

  • Table of Contents

    Dec 1, 2020, 00:00

  • Implementing Health Technology Assessments in Latin America: Looking at the Past, Mirroring the Future. A Perspective from the ISPOR Health Technology Assessment Roundtable in Latin America (Editor's Choice)

    Dec 1, 2020, 00:00

  • Multi-Criteria Model for Evaluating Drugs to Prevent Deep Venous Thrombosis Associated With Orthopedic Surgery: A Hospital-Based Case Study

    Dec 1, 2020, 00:00

  • Treatment With Liposomal Amphotericin B for All Confirmed Cases of Human Visceral Leishmaniasis in Brazil: A Budget Impact Analysis

    Dec 1, 2020, 00:00

  • Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data (Editor's Choice)

    Dec 1, 2020, 00:00

  • Copyright/Subscription

    Sep 12, 2020, 10:30

  • PSU8 Health Economic Evaluation of Protocol Change Including IV Iron Ferric Carboxymaltose Versus Control Group for HIP Surgery Patients with Iron Deficiency Anemia (IDA) in Korea

    Sep 1, 2020, 00:00

  • PRO5 IMPACT of Prophylaxis Costs in a Pediatric Patient Diagnosed with Severe Hemophilia a with Inhibitors in Guayaquil, Ecuador

    Sep 1, 2020, 00:00

  • PCN36 Cost-Effectiveness Analysis of Pembrolizumab Versus Nivolumab As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer in Germany

    Sep 1, 2020, 00:00

  • PIN37 Projection of Covid-19 Based on Decision Tree Analysis: WE Have NOT Won but WE Have NOT Lost the WAR!

    Sep 1, 2020, 00:00

  • PCV1 Cardiac Rehabilitation Program in a Tertiary Hospital in Peninsular Malaysia: Outcome and Associations

    Sep 1, 2020, 00:00

  • PCV13 Health Economic Evaluation of Screening and Treating Children with Familial Hypercholesterolemia EARLY in Life: Many Happy Returns on Investment?

    Sep 1, 2020, 00:00

  • Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland

    Sep 1, 2020, 00:00

  • PNS49 Building Capacity for HTA in the Philippines: An Imperative UNDER UHC

    Sep 1, 2020, 00:00

  • PNS27 Diffusion of Pharmaceutical Innovations in the Public Healthcare Setting in Malaysia

    Sep 1, 2020, 00:00

  • PMS6 Incidence and Prevalence of Osteoporosis and Related Fractures in ASIA and the Pacific: A Systematic Review

    Sep 1, 2020, 00:00

  • PIN31 The Epidemiology and Cost of Dengue Disease in Thailand: A Systematic Literature Review

    Sep 1, 2020, 00:00

  • PCN30 Comparison of Health Status Utilities of Breast Cancer with Comorbidities from the Korean National Health and Nutrition Examination Survey (KNHANES) 2008-2018

    Sep 1, 2020, 00:00

  • PIH13 Medications Risk and Pregnancy: Knowledge, Attitude, and Practice of Pharmacists in Gondar TOWN, North WEST Ethiopia. a CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PNS38 Creation of Favorable Conditions for the Development of the Clinical Trials Market

    Sep 1, 2020, 00:00

  • PSU10 The IMPACT of Post-Operative Complications on in-Hospital Cost Among 8130 Patients Undergoing Distal Gastrectomy in JAPAN: A Nationwide Registry Study

    Sep 1, 2020, 00:00

  • PRS1 Comparison of Clinical Outcomes Associated with Different Inhaler Devices in Asthma and COPD

    Sep 1, 2020, 00:00

  • PMD1 Effectiveness and Cost Analysis for Peripheral Inserted Central Catheter VS Central Venous Catheter in China

    Sep 1, 2020, 00:00

  • PMD11 Efficacy of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PIN50 Hepatitis B and C: Differences in Diagnosis and Treatment

    Sep 1, 2020, 00:00

  • PNS16 Health and Economic Burden of Smoking in Indonesia

    Sep 1, 2020, 00:00

  • PND29 Children with Hyperactive-Impulsive Disorder Benefit from Yoga Exercises

    Sep 1, 2020, 00:00

  • Disclosure Information

    Sep 1, 2020, 00:00

  • PCN49 Disease Burden of Classical Hodgkin Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PGI7 Cost-Effectiveness Analysis of Vonoprazan Versus Proton Pump Inhibitors in the Treatment of Reflux Esophagitis in China

    Sep 1, 2020, 00:00

  • Table of Contents

    Sep 1, 2020, 00:00

  • PCN38 Cost-Effectiveness of Mammography As a Screening Test for EARLY Detection of Breast Cancer

    Sep 1, 2020, 00:00

  • PIN45 Comparison of Antibiotics Policies between European Union Countries and JAPAN

    Sep 1, 2020, 00:00

  • PCV6 MODEL-Based Evaluation on Annual Economic Burden of Coronary Atherosclerotic Heart Disease in China

    Sep 1, 2020, 00:00

  • PCN80 Comparison of Treatment Among Chronic Myeloid Leukemia Patients in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • PMS14 CHILD with Cerebral Palsy Benefited from Motor Sequencing Training: Case Report

    Sep 1, 2020, 00:00

  • PCV20 A Real-World Study of Patient Characteristics and Treatment Patterns for Atrial Fibrillation in China

    Sep 1, 2020, 00:00

  • PMU11 Current Status of the Use of Prescription Opioids in Korean Elderly Patients: An Analysis of the Health Insurance Review and Assessment Service-Aged Patient Sample DATA

    Sep 1, 2020, 00:00

  • PNS72 Patients Are Playing an Increasing Role in Medical Decisions Due to the Digital Transformation of Healthcare in China

    Sep 1, 2020, 00:00

  • PNS70 EQ-5D-5L in China and JAPAN: Population Norms and Comparison between the Countries

    Sep 1, 2020, 00:00

  • PMU1 Dancing with the Dragon: Considerations and Learnings in the 2019 China National Reimbursement Drug LIST Negotiations

    Sep 1, 2020, 00:00

  • PRO13 In-Silico Determination of Therapeutic Possibilities for Type-1 Gaucher Disease: A GENE Database Linked Analysis

    Sep 1, 2020, 00:00

  • PCN52 Disease Burden of Prostate Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIN29 Evaluation of Healthcare Workers' Knowledge, Attitude and Practices Related to Covid-19: A Multicenter CROSS-Sectional Study from Pakistan

    Sep 1, 2020, 00:00

  • PCN92 An Investigation of Estimation Efficiency of Area UNDER the Curve (AUC) Using Parametric Models

    Sep 1, 2020, 00:00

  • PCN48 Cost-Effectiveness Analysis of Pertuzumab with Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Neoadjuvant Treatment of HER2-Positive EARLY or Locally Advanced Breast Cancer: Update Results after National ...

    Sep 1, 2020, 00:00

  • PNS14 Investigation of Physicians’ Digital Activities on Mitigating the IMPACT of Covid-19 in China

    Sep 1, 2020, 00:00

  • PND18 The Impact Of Anxiety Caused By Pharmacy Licence Examination Core Competency Of Fourth Year Pharmacy Students Of Burapha University 2018

    Sep 1, 2020, 00:00

  • PDG17 The Economic IMPACT Analysis of a Proposal to Abandon NON-Prescription Drug Reimbursement in Thailand, a Case Study of NON-Sedating Antihistamines

    Sep 1, 2020, 00:00

  • PNS53 Differences in Evidence Reviews Requirements for Health Technology Assessment (HTA) Document Development between Selected Countries

    Sep 1, 2020, 00:00

  • PMU8 The Increasing Burden of NON-Communicable Diseases in India

    Sep 1, 2020, 00:00

  • PCN95 A Systematic Literature Review of the Use of Mhealth Apps to Improve Quality of Life (QOL) in Cancer Patients

    Sep 1, 2020, 00:00

  • PDG23 Exploring the Determinants of Pharmaceutical Expenditure Growth: The Case of Cancer Drugs UNDER a Single-Payer System

    Sep 1, 2020, 00:00

  • PNS1 Real-World DATA Collection in China: Challenges and Recommendations to Ensure DATA Quality

    Sep 1, 2020, 00:00

  • PSU3 Clinical Outcomes and Economics Associated with Surgical Aortic Valve Replacement in Taiwan

    Sep 1, 2020, 00:00

  • PND30 Breathing Training HAS Positive Effect on Attention in Children with ADHD

    Sep 1, 2020, 00:00

  • PCN104 Treatment Patterns and Health Resource Utilization in Patients with HR+/HER2- Locally Advanced or Metastatic Breast Cancer in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • PAM4 Cost-Effectiveness of Dangguixu-SAN for Patients with Mild to Moderate Ankle Sprain

    Sep 1, 2020, 00:00

  • PCN28 Cost-Effectiveness Analysis of Avelumab for Treatment-Experienced and Treatment-Naïve Patients with Metastatic Merkel CELL Carcinoma in Taiwan

    Sep 1, 2020, 00:00

  • PCV7 Budget IMPACT Analysis on Fufang Xueshuantong Capsule in Treating Stable Angina Pectoris in China

    Sep 1, 2020, 00:00

  • Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema

    Sep 1, 2020, 00:00

  • PSY2 Evaluating Patient-Reported Outcomes and Work Productivity Among Patients with Psoriasis in Taiwan

    Sep 1, 2020, 00:00

  • PNS23 Setting Health Priorities in Low-Income and Middle-Income Countries in the ASIA-Pacific Region: The Case of Papua New Guinea

    Sep 1, 2020, 00:00

  • PCN26 Disease Burden of ACUTE Myelogenous Leukemia UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PSS1 IMPACT of ITCH on SLEEP in Adults with Atopic Dermatitis: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PND11 Pharmacoeconomic Evaluation of Multiple Sclerosis Therapy Costs in Central ASIA

    Sep 1, 2020, 00:00

  • PIH18 Characterizing the IMPACT of PDE5I Use on the Health and Economic Burden of Erectile Dysfunction in the US, JAPAN, and China

    Sep 1, 2020, 00:00

  • PCN106 Treatment Patterns and Health Resource Utilization in Patients with Hepatocellular Cancer (HCC) Following Failure of Sorafenib in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • PBI8 The Burden of Health Care Costs for Psoriasis Patients Treated with Biologics in South Korea

    Sep 1, 2020, 00:00

  • Productivity Loss in Patients With Chronic Diseases: A Pooled Economic Analysis of Hungarian Cost-of-Illness Studies [Editor's Choice]

    Sep 1, 2020, 00:00

  • PMU3 Medical Cost for Children with Infantile Hemangiomas in Southern China: Investigation Based on Medical Record DATA

    Sep 1, 2020, 00:00

  • PGI8 Facility Size-Based Diagnostic Patterns of the Crohn's Disease-Associated Perianal Fistula Using an Employer-Based Health Insurance Claims Database in JAPAN

    Sep 1, 2020, 00:00

  • PNS15 Effects of Different Family Planning Policies on Cesarean Section Rates from 2009 to 2019: A Population-Based Registry in China

    Sep 1, 2020, 00:00

  • PGI6 DISEASE BURDEN OF MODERATE TO SEVERE CROHN'S DISEASE UNDER CURRENT TREATMENT PATTERN IN CHINA

    Sep 1, 2020, 00:00

  • PNS9 The Potential IMPACT of External Reference Pricing Rules on Selected Drug Prices in China

    Sep 1, 2020, 00:00

  • PRS14 The IMPACT of Heart Failure on the Economic Burden of Various Phenotypes of Bronchial Obstructive Diseases

    Sep 1, 2020, 00:00

  • PMU6 Evaluation of the Application of the Hospital Management Program for Prevention and Treatment of Venous Thrombosis Based on Information Technology

    Sep 1, 2020, 00:00

  • PMU18 Budget IMPACT Analysis of the Eluvia Drug-Eluting Stent for Peripheral Artery Disease in Korea

    Sep 1, 2020, 00:00

  • PGI1 Systematic Review and Network Meta-Analysis of Infliximab, Adalimumab, Golimumab, Vedolizumab, Andtofacitinib for Moderate-to-Severe Ulcerative Colitis in ANTI-TNF-ALPHA-Naive Patients

    Sep 1, 2020, 00:00

  • PCN15 Disease Burden of Myelodysplastic Syndrome UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PCN1 IMPACT of PD-1/PD-L1 Inhibitors on Health Outcomes for Patients with Cancer in South Korea

    Sep 1, 2020, 00:00

  • PIH1 Development and Validation of a Prediction MODEL on Severe Maternal Outcomes Among Pregnant Women with PRE-Eclampsia: A 10-Year Cohort Study

    Sep 1, 2020, 00:00

  • PND23 Treatment Gaps in Deep Brain Stimulation for Patients with Parkinson's Disease: A Comparative Analysis of Nine High-Income Countries

    Sep 1, 2020, 00:00

  • PNS6 Risk Of Bias In Model-Based Economic Evaluations Of Tobacco Control Interventions In Asia: A Systematic Review

    Sep 1, 2020, 00:00

  • PMU21 Incorporating Preference Heterogeneity in Public Healthcare Policy Decision-Making: A Scoping Review of the Literature

    Sep 1, 2020, 00:00

  • PND6 Drug Utilization of Gastrodin Injection on the Treatment of Dizziness and Vertigo: An Analysis Using Electronic Medical Records in China

    Sep 1, 2020, 00:00

  • PRO3 Psoriasis As a PROXY for Health-Related Utility Values for Erythrodermic Cutaneous T-CELL Lymphoma

    Sep 1, 2020, 00:00

  • PCV24 Health Technology Assessment Submissions for Cardiovascular Interventions in the ASIA-Pacific Region

    Sep 1, 2020, 00:00

  • PMU9 Brand-Switching Behavior Following the Implementation of a 63% Tax Increase on Cigarettes in Taiwan

    Sep 1, 2020, 00:00

  • PDG16 Pharmaceutical Expenditure Monitoring for Price-Volume Negotiation in South Korea : Lessons and Improvement Points Learned over 11 YEARS

    Sep 1, 2020, 00:00

  • PRS4 Modeling Economic and Health Burden of Chronic Obstructive Pulmonary Disease (COPD) in China over the Next 20 YEARS

    Sep 1, 2020, 00:00

  • PND13 Burden of Illness of Spinal Muscular Atrophy: An Update

    Sep 1, 2020, 00:00

  • PCN76 Analysis of the Status of the MULTI-Indications for Anticancer Drugs and Their Price Reduction in South Korea

    Sep 1, 2020, 00:00

  • PIN53 The Usability Testing of the Integrated E-Healthcare Services (IEHS) Web-Based Application in the Therapy Management of HIV and Tuberculosis in Indonesia

    Sep 1, 2020, 00:00

  • PRS15 Evaluating Disease and Economic Burden of Severe Asthma in India

    Sep 1, 2020, 00:00

  • PMU26 The Health-Related Quality of Life in Different Disease Population Based on EQ-5D-5L: A Systematic Review

    Sep 1, 2020, 00:00

  • PDG20 Availability and Affordability of Oncologic Immunotherapies across Multiple-Countries

    Sep 1, 2020, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »